Medline, a Northfield, Ill.-based major medical supplier, made several headlines in 2024 for key developments—from its partnership with a tech giant to earning industry accolades for supply chain ...
The drugs are listed in alphabetical order. Adalimumab-Adbm injection: Boehringer Ingelheim Pharmaceuticals discontinued two presentations of Cyltezo, its biosimilar to Humira. The injectable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback